Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 430 of 6351
-
See your arteries, save your heart: new trial targets Post-Pregnancy hypertension
Disease control Not yet recruitingThe GESTA-COR study is a prospective, non-commercial, randomized clinical trial designed to evaluate the impact of detailed vascular imaging feedback on the management of cardiovascular health in women with a history of adverse pregnancy outcomes (APOs). The trial aims to determi…
Sponsor: Maternal-Infantil Vall d´Hebron Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New injections aim to shrink Hard-to-Treat skin tumors
Disease control Recruiting nowOpen label, randomized study in patients with LaBCC not eligible or refusing surgery or radiation therapy according to the evaluation of a local interdisciplinary tumor board. The primary objective of the study is to evaluate the efficacy of L19IL2 or L19TNF or L19IL2/L19TNF, the…
Phase 2 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New hope for rare kidney cancer: drug trial targets tough tumors
Disease control Not yet recruitingTo learn if sacituzumab tirumotecan can help to control advanced or metastatic SMARCB1-deficient RMC in patients whose disease has progressed after receiving at least 1 treatment.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Poop pills could stop deadly bile duct infections
Disease control Not yet recruitingPatients with abnormalities of the biliary tract (the system that connects the liver to the small intestine and allows bile to flow) are prone to the development of strictures, dilations, or other problems that impede bile flow and promote the formation of gallstones. All of this…
Phase 2 • Sponsor: Puerta de Hierro University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug cocktail aims to shrink liver tumors for surgery
Disease control Not yet recruitingThis study is a single-center, prospective, randomized, single-arm phase II clinical trial designed to evaluate the safety and efficacy of FULIRI chemotherapy regimen combined with targeted therapy (bevacizumab/cetuximab) as first-line conversion therapy for colorectal cancer wit…
Phase 2 • Sponsor: Zhongnan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Triple-Drug combo aims to stop AML relapse after remission
Disease control Not yet recruitingStudy Objectives: To evaluate the Relapse-Free Survival (RFS) and 1-year RFS rate in patients with Acute Myeloid Leukemia (AML) receiving maintenance therapy with Chidamide combined with Venetoclax and Azacitidine. Study Design: Prospective, Multicenter, Interventional Cohort …
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Gene-Edited immune cells take on autoimmune blood diseases
Disease control Recruiting nowThis is a single-arm, open-label, multicenter, ascending dose Phase 1/2 trial evaluating the safety and preliminary efficacy of CTX112 or Zugocabtagene geleucel (zugo-cel) in adult participants with relapsed/refractory primary Immune Thrombocytopenia (ITP) and relapsed/refractory…
Phase 1/2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug challenger takes on leading therapy for advanced breast cancer
Disease control Not yet recruitingThis study is a prospective, open-label, multicenter, randomized, parallel Phase II clinical trial. This study aims to investigate the efficacy and safety of trastuzumab rezetecan or trastuzumab deruxtecan in HER2 positive advanced/metastastic breast cancer
Phase 2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New 'Off-the-Shelf' CAR-T therapy takes on Hard-to-Treat myeloma
Disease control Not yet recruitingThis is a prospective, single-arm, open-label, early exploratory clinical study designed to evaluate the safety, tolerability, and efficacy of the DQ1001 cell product in patients with relapsed or refractory multiple myeloma. All participants will receive intravenous infusions of …
Phase 1 • Sponsor: Zhongshan Hospital (Xiamen), Fudan University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug duo aims to wipe out bladder tumors before surgery
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of neoadjuvant trastuzumab rezetecan combined with adebrelimab for the treatment of HER2-positive muscle-invasive bladder cancer.
Phase 2 • Sponsor: Harbin Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Triple-Drug cocktail aims to boost ovarian cancer surgery success
Disease control Recruiting nowThe R0 resection rate in neoadjuvant chemotherapy for advanced ovarian cancer remains below 50%, indicating unmet clinical needs. Tyrosine kinase inhibitors (TKIs) can induce immune microenvironment remodeling and exhibit synergistic effects with immune checkpoint inhibitors. To …
Phase 2 • Sponsor: Bai-Rong Xia • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a daily glass of kefir during pregnancy ward off gestational diabetes?
Prevention Not yet recruitingPregnancy is a critical window for metabolic health, and early changes in blood sugar regulation can increase the risk of gestational diabetes mellitus (GDM), which affects both maternal and infant health. At the same time, the maternal gut microbiome changes throughout pregnancy…
Sponsor: University of New Brunswick • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
Glowing light could spot oral cancer before it starts
Prevention By invitation onlyPatients attending the Department of Oral Mucosal and Periodontal Diseases at the University Dental Center of the Medical University of Warsaw who provide written informed consent will be invited to participate in the study. Participation will begin with completing a short, anon…
Sponsor: Medical University of Warsaw • Aim: Prevention
Last updated Jul 08, 2026 00:00 UTC
-
Smart bomb for kidney cancer: imaging and radiation combo targets tough tumors
Disease control Recruiting nowThis is an open-label, multicenter, Phase 1a/1b study evaluating the theranostic pair 64Cu-PD-32766 Injection (PD-32766D) and 225Ac-PD-32766 Injection (PD-32766T) in adult patients with relapsed or refractory Carbonic Anhydrase IX (CA9)-expressing clear cell renal cell carcinoma …
Phase 1 • Sponsor: PeptiDream Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Engineered immune cells take on incurable blood cancer
Disease control Recruiting nowThe treatment options for multiple myeloma have evolved significantly over the years, providing patients with a range of therapies tailored to their specific circumstances. The choice of treatment often hinges on various factors, including the aggressiveness of the disease, indiv…
Phase 2 • Sponsor: Dr. Zaineb Akram • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Prison program aims to alert partners of HIV risk
Disease control Not yet recruitingAssisted partner notification (APN) is a voluntary and confidential process that utilizes specially-trained health workers to encourage and assist people diagnosed with HIV to inform their sex and drug use partners about possible shared exposure to HIV. With APN, partners who hav…
Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Ear seeds and smart glasses: a new hope to halt childhood myopia?
Prevention Recruiting nowThis is a prospective, school-based randomized controlled trial designed to evaluate auricular acupressure combined with defocus spectacle lenses for myopia control in primary school students with premyopia or myopia. Enrolled students in grades 1 to 4 will be randomly assigned t…
Sponsor: Shanghai Eye Disease Prevention and Treatment Center • Aim: Prevention
Last updated Aug 07, 2026 00:00 UTC
-
Can a new PET tracer outsmart head and neck cancer metastases?
Diagnosis CancelledThe purpose of this study is to determine the diagnostic utility of 89Zr-panitumumab to identify metastatic lesion(s) in subjects with head and neck squamous cell carcinoma (HNSCC).
Phase 2 • Sponsor: Andrei Iagaru • Aim: Diagnosis
Last updated Aug 19, 2026 00:00 UTC
-
Can a mineral ease severe headaches faster than standard painkillers?
Symptom relief Recruiting nowHeadache is one of the most common reasons for consultation in emergency departments and represents a significant cause of disability, particularly in patients with migraine and other primary headache disorders. Despite the availability of several analgesic treatments, including …
Sponsor: University of Monastir • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
A week of dieting before liver surgery could cut bleeding and complications
Disease control Recruiting nowThe rationale for this study is to evaluate whether a standardized, preoperative, short-term Low Calorie Diet (LCD) reduces intraoperative bleeding and postoperative morbidity in liver surgery. Participants with a BMI of 30 or higher, scheduled for liver surgery, if accepting pa…
Sponsor: Region Skane • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC